Tanja Scheikl,1,
Bernhard Reis,2,
Norbert Hüser,1
Klaus Pfeffer,2 and
Bernhard Holzmann1*
Department of Surgery, Technische Universität München, 81675 Munich, Germany,1 Institute of Medical Microbiology, Universität Düsseldorf, 40225 Düsseldorf, Germany2
Received 4 July 2005/ Accepted 27 July 2005
Adaptive immunity is crucial for protective host defense and the development of immunological disorders. SLY1 was recently identified as an X-chromosomal SH3 protein that is serine phosphorylated (Ser27) upon B-and T-cell receptor engagement. Here, we demonstrate that SLY1 is localized in the cytoplasm and the nucleus of immunocytes. We generated mice expressing a mutant version of SLY1 lacking Ser27 and a functional nuclear localization signal. The defective SLY1 (SLY1d) protein is localized exclusively in the cytoplasm. B- and T-cell proliferation is attenuated and T-cell cytokine production is severely reduced. Sly1d/d mice exhibit reduced lymphoid organ sizes, diminished marginal zone B-cell numbers, and severely impaired antibody responses against T-dependent and -independent antigens. Importantly, survival of semi-identical cardiac allografts was substantially prolonged in Sly1d/d mice. These results define SLY1 as an essential molecular component for the full activation of adaptive immunity.
These authors contributed equally to this work.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|